Frontlight ResearchEarly access
Trial site
China Pharmaceutical University, Shanghai Gobroad Cancer Hospital
- 2running trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Liver and biliary tract cancer2 trials
- Kidney cancer1 trial
- Phase
- Phase 22 trials
- Status
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Zhejiang Haichang Biotech Co., Ltd.2 trials
Running trials
Not yet recruiting
Phase 2 Study of WGI-0301 Plus Nivolumab in Patients With HCC and RCC
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Liver and biliary tract cancer2 recruiting
- Kidney cancer1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026